KEYPOINTS: Zydus Cadila has received final approval from the US FDA to market Nelarabine injection…
Active Pharmaceutical Ingredients (API)Risankizumab
European Commission approves AbbVie’s Skyrizi (Risankizumab) to Treat Adults with Active Psoriatic Arthritis.
KEYPOINTS: AbbVie announces that the European Commission (EC) has approved SKYRIZI (Risankizumab, 150 mg, subcutaneous…
Active Pharmaceutical Ingredients (API)carmustineCompaniesDr. Reddy`s
Keypoints: Reddy’s Laboratories Ltd. has recently announced the launch of Carmustine for Injection, USP. Carmustine,…